| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| ATC: | L03AB15 |
| UNII: | 981TME683S |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| POSITIVE MODULATOR | Interferon alpha/beta receptor positive modulator |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis C, Chronic | 3 | D019698 | ClinicalTrials |
| Thrombocythemia, Essential | 3 | D013920 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
| Hepatitis D | 2 | D003699 | ClinicalTrials |
| Hepatitis B, Chronic | 1 | D019694 | ClinicalTrials |
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1335098-50-4 |
| ChEMBL | CHEMBL4297819 |
| FDA SRS | 981TME683S |
| PubChem | 86278347 |
CONTENTS